Proteomic Analysis Reveals Low-Dose PARP Inhibitor-Induced Differential Protein Expression in BRCA1-Mutated High-Grade Serous Ovarian Cancer Cells

[Image: see text] High-grade serous ovarian cancer (HGSOC) is the most common form of ovarian cancer diagnosed in patients worldwide. Patients with BRCA1/2-mutated HGSOC have benefited from targeted treatments such as poly(ADP-ribose) polymerase inhibitors (PARPi). Despite the initial success of PAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Jesenia M., Twigg, Carly A. I., Guan, Weihua, Thomas, Stefani N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824432/
https://www.ncbi.nlm.nih.gov/pubmed/34958553
http://dx.doi.org/10.1021/jasms.1c00215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824432/
https://www.ncbi.nlm.nih.gov/pubmed/34958553
http://dx.doi.org/10.1021/jasms.1c00215

Ejemplares similares